Global mTOR (Mammalian target of rapamycin) Inhibitors Market 2019-2023

Global mTOR (Mammalian target of rapamycin) Inhibitors Market 2019-2023

About this market

The strong prevalence of oncology indications is one of the key factors expected to trigger market growth during the forecast period. Vendors are conducting studies on target specific drugs to meet the gap between the demand and supply of these therapies. Factors including the increasing geriatric population and changes in lifestyle have also contributed to the oncology indications, in turn, contributing to the mTOR Inhibitors market growth during the forecast period. Technavio’s analysts have predicted that the mTOR inhibitors market will register a CAGR of over 3% by 2023.

Market Overview

Introduction of novel drug delivery systems and combination therapies

Chemotherapeutic drugs are mostly administered through conventional methods to treat different tumors. And, it is observed that the API does not reach the targeted site in appropriate quantities, thus lowering the performance of the drugs.

Adverse effects of available therapeutics

Despite being highly efficacious, mTOR inhibitors used for treating various oncology indications are associated with a spectrum of side effects. These side effects hinder patient adherence to the treatment, which poses a challenge to market growth.

For the detailed list of factors that will drive and challenge the growth of the mTOR inhibitors market during 2019-2023, view our report.

Competitive Landscape

The market appears to be concentrated and with the presence of few companies including Biocon Ltd. and Intas Pharmaceuticals Ltd., the competitive environment is quite intense. Various international and national organizations are focusing on conducting programs to increase awareness about cancer and help early diagnosis of the disease. Novartis AG, Pfizer Inc., and Zydus Cadila. are some of the major companies covered in this report.


Companies Mentioned

Biocon Ltd.

Intas Pharmaceuticals Ltd.

Novartis AG

Pfizer Inc.

Zydus Cadila

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by RoA
    • Table RoA - Market share 2018-2023 (%)
    • Comparison by RoA
      • Table Comparison by RoA
    • Oral therapy - Market size and forecast 2018-2023
      • Table Oral therapy - Market size and forecast 2018-2023 ($ millions)
      • Table Oral therapy - Year-over-year growth 2019-2023 (%)
      • Table Pipeline molecules with oral RoA
    • Intravenous therapy - Market size and forecast 2018-2023
      • Table Intravenous therapy - Market size and forecast 2018-2023 ($ millions)
      • Table Intravenous therapy - Year-over-year growth 2019-2023 (%)
    • Market opportunity by RoA
      • Table Market opportunity by RoA
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table New cases of cancer in US: 2015
    • Market challenges
      • Table Alternative therapies for oncology indications for which mTOR inhibitors are used
      • Table Side effects of mTOR inhibitors
      • Table Impact of drivers and challenges
  • Market trends
    • Table Approved drugs with respect to their cancer indications
    • Table Expansion of research areas of mTOR inhibitors
    • Table Patient assistance programs
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Biocon Ltd.
      • Table Biocon Ltd. - Vendor overview
      • Table Biocon Ltd. - Business segments
      • Table Biocon Ltd. - Organizational developments
      • Table Biocon Ltd. - Geographic focus
      • Table Biocon Ltd. - Segment focus
      • Table Biocon Ltd. - Key offerings
      • Table Biocon Ltd. - Key customers
    • Intas Pharmaceuticals Ltd.
      • Table Intas Pharmaceuticals Ltd. - Vendor overview
      • Table Intas Pharmaceuticals Ltd. - Business segments
      • Table Intas Pharmaceuticals Ltd. - Organizational developments
      • Table Intas Pharmaceuticals Ltd. - Key offerings
      • Table Intas Pharmaceuticals Ltd. - Key customers
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
    • Zydus Cadila
      • Table Zydus Cadila - Vendor overview
      • Table Zydus Cadila - Business segments
      • Table Zydus Cadila - Organizational developments
      • Table Zydus Cadila - Geographic focus
      • Table Zydus Cadila - Key offerings
      • Table Zydus Cadila - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook